A Question Asked You can ask any question about any stock and they will answer. may not be your expectations but they give their honest independent answer /opinion. There is also have 3 model portfolios , balanced , dividend and growth . Currently , Exro is not in the growth model portfolio . The last question asked about EXRO was Sept 11/2023 . Exro is not exactly a high-profile stock for retail investor subscribers of the service either wise they would get peppered with all kinds of questions about Exro. Questions and answers to the multiple of stocks that subscribers of the service ask 5 days a week . Like the answers or not here's the views supplied .
Reminder for those who don't know me I'm breaking copywrite but I'm willing to keep the Exro Stockhouse members up to date. I spend a significant amount of dollars yearly researching through services.
GLTA
Symbol(s): Exro Technologies Inc. (EXRO)
Date: Nov 23, 2023 10:31 AM
Question: This stock hit hard today down 12%,I am down 50% in one year is this worth holding for say 6 months to a year. Today's news was on lifting a NDA ban on a deal with Brazil I think,could you give me your thoughts on this company in regards to management,products and burn rate and is it a BSH Thanks
Answer:
Cash flow was negative $31M last year, and negative $13M in the recent 3Q alone. The balance sheet is OK, with cash offsetting debt and leases. We would consider management competent, but the company has such a tiny revenue base it is hard to analyze. Management has gotten it to this point and revenue is expected to ramp quickly next year. It only had $2M in sales in the quarter, and lost $11M. It is going to need more capital. The technology looks fine, but we would prefer more sales just to get third-party validation. We are not experts in the field and sales go a long way in such confirmations. Any small cap needs patience, but we think buyers have lots of time here. With minimal sales and a $225M market cap, a lot is priced in. We would be comfortable exiting, with a view to reexamine on the next capital raise by the company.
So says 5iResearch